Aandeel A102940 KOLON LIFE SCIENCE INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Kolon Life Science Inc.

Aandelen

A102940

KR7102940004

slotkoers Korea S.E.
Andere beurzen
 00:00:00 21-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
22.100 KRW +2,08% Intraday-grafiek van Kolon Life Science Inc. -1,12% -14,01%
20/03 Kolon Life Science Inc. Rapporteert winstresultaten voor het gehele jaar eindigend op 31 december 2023 CI
2023 Kolon Life Science Inc. rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Kolon Life Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Kolon Biotech, Inc. announced that it has received KRW 2.001 billion in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it expects to receive KRW 2.0068 billion in funding from Kolon Life Science Inc.
Kolon Life Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Kolon Life Science Inc.(KOSDAQ:A102940) added to S&P Global BMI Index
Kolon Life Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Kolon Biotech, Inc. announced that it has received KRW 5.112 billion in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it expects to receive KRW 5.112 billion in funding from Kolon Life Science Inc.
Kolon Life Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Kolon Biotech, Inc. announced that it expects to receive KRW 994 million in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it expects to receive KRW 1.5 billion in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it expects to receive KRW 1.005 billion in funding from Kolon Life Science Inc.
Kolon Life Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Kolon Biotech, Inc. announced that it expects to receive KRW 2.511 billion in funding from Kolon Life Science Inc.
Kolon Life Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Kolon Biotech, Inc. announced that it expects to receive KRW 2.499 billion in funding from Kolon Life Science Inc.
Kolon Life Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Kolon Biotech, Inc. announced that it has received KRW 5.562 billion in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it expects to receive KRW 5.562 billion in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it has received KRW 5.06 billion in funding from Kolon Life Science Inc.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers A102940
  4. Nieuws Kolon Life Science Inc.
  5. Andere talen
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU